Catalyst Wire Dossier Catalyst Wire Dossier

YUVEZZI

CARBACHOL AND BRIMONIDINE TARTRATE · Visus Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YUVEZZI, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: FDA Approved: YUVEZZI — Original Application (Visus Therapeutics, Inc.)

See pricing